CClinicalTrials.gg
RecruitingNCT07544914rPMSUpdated Sep 29, 2026

Effects of Peripheral Repetitive Peripheral Magnetic Stimulation on Individuals With Elbow or Wrist Chronic Pain

An interventional study of Two days Active rPMS and Two days Sham rPMS in Tennis Elbow Syndrome, Golfer's Elbow and Carpal Tunnel Syndrome (CTS), sponsored by University of Manitoba. Recruiting at 1 site in Canada. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-09-29.

Sponsored by University of Manitoba · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

This pilot, randomized, sham-controlled, single-blind study will evaluate the effectiveness of repetitive peripheral magnetic stimulation (rPMS) in reducing pain in adults with tennis/golfer's elbow or carpal tunnel syndrome. Approximately 40 participants will be randomly assigned to active or sham stimulation delivered over two consecutive days. Outcomes, including pressure pain threshold, subjective pain ratings, and local tissue oxygenation (fNIRS), will be assessed at baseline, immediately post-intervention, and during follow-up up to 6 months to evaluate both clinical effects and underlying physiological mechanisms.

Read the detailed description

Objectives - The primary objective is to investigate the effect of active repetitive peripheral magnetic stimulation (rPMS) in reducing pain in individuals with either tennis/golfer elbow syndrome (either medial or lateral epicondylitis) or carpal tunnel syndrome in a pilot randomized placebo-controlled clinical trial. The secondary objective is to investigate the duration of the rPMS effects up to 6 months.

Study Population - The study population will consist of two groups of individuals: one group including 10 with tennis/golfer elbow syndrome and second group including 10 with carpal tunnel syndrome. Participants will be recruited from volunteers by advertising and/or doctors' referral.

Research Design and Study Procedure - This study design is a parallel-cohort exploratory single-blind, randomized, sham-controlled study investigating the effect of rPMS in pain reduction in individuals with either elbow or wrist chronic pain. Eligible participants in each group will be stratified by condition (elbow vs carpal tunnel) and randomized within each stratum to active or sham rPMS. The sham group participants will have the option to receive the active treatment after a month of receiving the sham treatment.

The rPMS protocol is two consecutive days of therapy. In each day, the participants will receive 400 pulses at 10 HZ in 1.5 sec trains with 10-second intertrain intervals. All participants will be assessed for their pain levels at baseline, immediately post-intervention, one week after the intervention and then every month up to 6 months follow-up sessions.

The assessments include subjective Visual Analogue Scale (VAS) score for pain on a scale of 0 to 10, the minimum pressure pain threshold (PPT) and near-infrared spectroscopy (NIRS) over the target area.

02

Conditions studied

  • Tennis Elbow Syndrome
  • Golfer's Elbow
  • Carpal Tunnel Syndrome (CTS)

Keywords

  • rPMS
  • elbow
  • wrist
  • chronic pain
  • NIRS
03

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Clinical diagnosis or self-reported history consistent with either medial or lateral epicondylitis or carpal tunnel syndromes.
  • Presence of chronic pain in the target area (mentioned above) at the time of enrollment.
  • Ability to understand the study procedures and provide informed consent.

Exclusion criteria

Exclusion Criteria:

  • Contraindications to peripheral magnetic stimulation, including implanted electronic medical devices or metallic implants in locations deemed unsafe for stimulation.
  • Open wounds, active skin conditions, or other local conditions at the stimulation site.
  • Current neurological, musculoskeletal, or systemic medical conditions that, in the opinion of the investigators, would interfere with safe participation or interpretation of study outcomes.
  • Current upper-limb injury or condition other than tennis/golfer elbow or carpal tunnel syndromes that could confound pain or perfusion measurements.
  • Pregnancy.
  • Inability to tolerate the stimulation or measurement procedures.
  • Inability to adequately understand study instructions or provide informed consent.
04

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
40 participants (estimated)

Study arms

  • Experimental
    Two days active rPMS - Tennis/golfer syndrome

    Participants of this arm, suffer from chronic pain at elbow either medial or lateral epicondylitis (tennis/golder syndromes) and receive real rPMS pulses as treatment for two days successively, each day 300 pulses at 10 Hz.

    Device: Two days Active rPMS

  • Sham comparator
    Two days sham rPM - Tennis/golfer syndrome

    Participants of this arm, suffer from chronic pain at elbow either medial or lateral epicondylitis (tennis/golder syndromes) and receive SHAM rPMS pulses as treatment for two days successively, each day 300 pulses at 10 Hz.

    Device: Two days Sham rPMS

  • Experimental
    Two days Active rPMS - Carpal Tunnel Syndrome

    Participants of this arm, suffer from chronic pain at wrist (carpal tunnel syndrome) and receive REAL rPMS pulses as treatment for two days successively, each day 300 pulses at 10 Hz.

    Device: Two days Active rPMS

  • Sham comparator
    Two days Sham rPMS - Carpal Tunnel syndrome

    Participants of this arm, suffer from chronic pain at wrist (carpal tunnel syndrome) and receive SHAM rPMS pulses as treatment for two days successively, each day 300 pulses at 10 Hz.

    Device: Two days Sham rPMS

Interventions

  • DeviceTwo days Active rPMS

    It is a magnetic coil with a device that creates electromagnetic pulses. The Real one gives pulses with 100% intensity.

  • DeviceTwo days Sham rPMS

    Sham coil gives very weak pulses off target that does not penetrate to the skin.

05

What researchers measure

Primary outcomes

  1. Change in pain pressure threshold (PPT)

    PPT is measured by a pressure altimeter and identifies the minimum pressure that the subject feels pain.

    Time frame: from baseline to post-treatment assessments on day 3 and week2 up to 6 months follow-up.

Secondary outcomes

  1. Change in visual subjective pain scale

    the visual subjective pain scale is a score using 0 to 10 on the pain level.

    Time frame: from Pre-intervention to post on day 3, week 1 and other post assessments up to 6 months.

06

Study locations

1 of 1 sites recruiting
  • Riverview Health Center
    Winnipeg, Manitoba R3L 2P4, Canada
    Recruiting
07

References and documents

Individual participant data

Plan to share: Undecided — This is a small pilot study. Once there is enough data with good quality, the investigators will consider data sharing.

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT07544914
Lead sponsor
University of Manitoba
Responsible party
Dr. Zahra Kazem-Moussavi (Professor, University of Manitoba) — Principal investigator
First posted
Apr 22, 2026
Start date
Jul 1, 2026
Primary completion
Aug 30, 2027 (estimated)
Completion
Dec 30, 2027 (estimated)
Last update
Sep 29, 2026

Study contacts

Mari Garcia, M.Sc.
Contact
MARITERE.GARCIACAMPUZANO@umanitoba.ca
(204) 478-6352
Zahra Moussavi, Ph.D.
Contact
Zahra.Moussavi@umanitoba.ca
204-474-7023
Zahra Moussavi
principal investigator · University of Manitoba

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion